Study of Default Options in Advance Directives

Sponsor
Corporal Michael J. Crescenz VA Medical Center (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT01817686
Collaborator
(none)
62
1
3
27
2.3

Study Details

Study Description

Brief Summary

Default options represent the events or conditions that are set into place if no alternatives are actively chosen. The setting of default options has well-established effects on a broad range of human decisions, but its influence on patients' preferences for end-of-life care is only beginning to be understood.

This is a 3-armed randomized clinical trial in Veterans at high risk for critical illness, assessing the impact of Advance Directive (AD) forms framed with different default options. The central goals are to assess how default options in ADs influence the end-of-life care choices made by patients at risk for critical care, and these patients' hospital and ICU utilization.

The investigators hypothesize that setting defaults in real ADs will increase the proportion of Veterans selecting comfort-oriented plans of care, decrease selections of life-extending therapies such as mechanical ventilation and dialysis, and reduce the proportion of time during follow-up that Veterans spend in the hospital and/or ICU, without affecting patient satisfaction with end-of-life care planning.

Study Design

Study Type:
Interventional
Actual Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Health Services Research
Official Title:
Default Options in Advance Directives for Veterans With Serious Illnesses: A Randomized Clinical Trial
Study Start Date :
Mar 1, 2013
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Comfort Default

ADs with pre-selected defaults that focus on providing comfort at end-of-life.

Other: Comfort Default AD forms
Consenting subjects will be randomly assigned to one of 3 study arms. Subjects will receive a different AD form based on which arm they have been randomly assigned. Once a completed AD form is received, a debriefing session will be held to alert patients to exactly how the 3 ADs used in the study differ. Once patients are fully informed about the variations in the ADs, the patients will have an opportunity to change their AD selections prior to finalizing them as a part of their medical record. A final satisfaction interview will take place with a research associate who will contact patients via telephone to administer a satisfaction questionnaire.

Experimental: Life Extension Default

ADs with pre-selected defaults that focus on extending life.

Other: Life Extension Default AD forms
Consenting subjects will be randomly assigned to one of 3 study arms. Subjects will receive a different AD form based on which arm they have been randomly assigned. Once a completed AD form is received, a debriefing session will be held to alert patients to exactly how the 3 ADs used in the study differ. Once patients are fully informed about the variations in the ADs, the patients will have an opportunity to change their AD selections prior to finalizing them as a part of their medical record. A final satisfaction interview will take place with a research associate who will contact patients via telephone to administer a satisfaction questionnaire.

Experimental: Standard Default

ADs without pre-selected defaults.

Other: Standard Default AD forms
Consenting subjects will be randomly assigned to one of 3 study arms. Subjects will receive a different AD form based on which arm they have been randomly assigned. Once a completed AD form is received, a debriefing session will be held to alert patients to exactly how the 3 ADs used in the study differ. Once patients are fully informed about the variations in the ADs, the patients will have an opportunity to change their AD selections prior to finalizing them as a part of their medical record. A final satisfaction interview will take place with a research associate who will contact patients via telephone to administer a satisfaction questionnaire.

Outcome Measures

Primary Outcome Measures

  1. Evaluate how the setting of defaults influences the proportion of Veterans selecting comfort-oriented plans of care in real ADs [18 months]

    The primary outcome is the proportion of patients in each of the 3 groups who select a general plan of care that prioritizes comfort over life extension.

Secondary Outcome Measures

  1. Assess the influence of default options in ADs on Veterans' selections of specific life-extending therapies [18 months]

    The proportions of patients electing to receive each of the 5 specific life-extending interventions

  2. Determine whether setting defaults in ADs influences the proportion of time during follow-up that Veterans spend in the hospital or ICU [18 months]

    The proportion of time during a 6-18 month follow-up (median 1 year) that patients spend in the hospital or ICU for each AD group

Other Outcome Measures

  1. To document feasibility of a study of Advance Directives in the Veteran population [18 months]

    To document our ability to recruit and retain patients with advanced diseases, we will measure the proportions of patients approached for consent who enroll (consent rate), the proportion of such patients who complete their AD (completion rate), and the proportion who subsequently complete their advance care satisfaction interview (retention rate).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 years

  • Chronic Obstructive Pulmonary Disease (COPD) with severe or very severe airflow obstruction on pulmonary function testing and or receiving or eligible to receive long-term oxygen therapy AND/OR

  • Idiopathic Pulmonary Fibrosis (IPF) AND/OR

  • Other interstitial lung disease without curative therapy AND/OR

  • Any stage 3B or 4 solid tumor AND/OR

  • Congestive Heart Failure (CHF) either New York Heart Association NYHA) class IV or NYHA class III plus 1 hospitalization in the past year

  • No previously signed advance directive in the medical record

  • Neither listed for nor considering lung or heart transplantation

  • High anticipated risk for critical illness in the next 2 years based on clinical judgment

  • Interest in thinking about filling out an Advance Directive

Exclusion Criteria:
  • Diseases for which life-extending medical therapies may be available

  • Inability to speak and/or read English proficiently

  • New clinic patients meeting the clinic provider for the first time

  • Patients being actively evaluated or already listed for transplants

  • Patients already having an AD

  • Cognitive impairment necessitating proxy consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Philadelphia Veterans Affairs Medical Center Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • Corporal Michael J. Crescenz VA Medical Center

Investigators

  • Principal Investigator: Joshua B Kayser, MD, MPH, Corporal Michael J. Crescenz VA Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Joshua B. Kayser, Assistant Professor of Clinical Medicine, Corporal Michael J. Crescenz VA Medical Center
ClinicalTrials.gov Identifier:
NCT01817686
Other Study ID Numbers:
  • 01381
First Posted:
Mar 25, 2013
Last Update Posted:
Jun 30, 2015
Last Verified:
Jun 1, 2015

Study Results

No Results Posted as of Jun 30, 2015